documents: FDA-2006-N-0040-0098

Regulatory documents from Regulations.gov including rules, proposed rules, notices, and supporting materials.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id agency_id docket_id title document_type subtype posted_date posted_year posted_month comment_start_date comment_end_date last_modified fr_doc_num open_for_comment withdrawn object_id
FDA-2006-N-0040-0098 FDA FDA-2006-N-0040 Reference 77-11 Regulatory Impact Analysis Prevalence, incidence, and residual risk of human immunodeficiency virus and hepatitis C virus infections re Requirements for Blood and Blood Components Intended for Transfusion or for Further Manufacturing Use Supporting & Related Material Background Material 2015-05-22T04:00:00Z 2015 5     2015-05-22T19:32:34Z   0 0 0900006481aef9aa

Links from other tables